{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:04:17Z","timestamp":1773331457655,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The HealthHumanities Research Center of China","award":["JKRWZ23-04"],"award-info":[{"award-number":["JKRWZ23-04"]}]},{"name":"The HealthHumanities Research Center of China","award":["JKRWZ23-04"],"award-info":[{"award-number":["JKRWZ23-04"]}]},{"name":"The HealthHumanities Research Center of China","award":["JKRWZ23-04"],"award-info":[{"award-number":["JKRWZ23-04"]}]},{"name":"The HealthHumanities Research Center of China","award":["JKRWZ23-04"],"award-info":[{"award-number":["JKRWZ23-04"]}]},{"name":"The HealthHumanities Research Center of China","award":["JKRWZ23-04"],"award-info":[{"award-number":["JKRWZ23-04"]}]},{"name":"The HealthHumanities Research Center of China","award":["JKRWZ23-04"],"award-info":[{"award-number":["JKRWZ23-04"]}]},{"name":"The HealthHumanities Research Center of China","award":["JKRWZ23-04"],"award-info":[{"award-number":["JKRWZ23-04"]}]},{"name":"The HealthHumanities Research Center of China","award":["JKRWZ23-04"],"award-info":[{"award-number":["JKRWZ23-04"]}]},{"name":"Sichuan Tianfu Aging Industry Development Research Centre of China","award":["TFLLCY2331"],"award-info":[{"award-number":["TFLLCY2331"]}]},{"name":"Sichuan Tianfu Aging Industry Development Research Centre of China","award":["TFLLCY2331"],"award-info":[{"award-number":["TFLLCY2331"]}]},{"name":"Sichuan Tianfu Aging Industry Development Research Centre of China","award":["TFLLCY2331"],"award-info":[{"award-number":["TFLLCY2331"]}]},{"name":"Sichuan Tianfu Aging Industry Development Research Centre of China","award":["TFLLCY2331"],"award-info":[{"award-number":["TFLLCY2331"]}]},{"name":"Sichuan Tianfu Aging Industry Development Research Centre of China","award":["TFLLCY2331"],"award-info":[{"award-number":["TFLLCY2331"]}]},{"name":"Sichuan Tianfu Aging Industry Development Research Centre of China","award":["TFLLCY2331"],"award-info":[{"award-number":["TFLLCY2331"]}]},{"name":"Sichuan Tianfu Aging Industry Development Research Centre of China","award":["TFLLCY2331"],"award-info":[{"award-number":["TFLLCY2331"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-75895-z","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T12:01:53Z","timestamp":1729080113000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical analysis of bleeding and thrombotic events in haematological-oncology patients with severe thrombocytopenia and a high risk of thrombosis"],"prefix":"10.1038","volume":"14","author":[{"given":"Jing","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Gou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiumei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Die","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,16]]},"reference":[{"issue":"Suppl 1","key":"75895_CR1","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/S0049-3848(20)30389-3","volume":"191","author":"F Moik","year":"2020","unstructured":"Moik, F., Ay, C. & Pabinger, I. Risk prediction for cancer-associated thrombosis in ambulatory patients with cancer: past, present and future. Thromb. Res.191(Suppl 1), S3\u201311 (2020).","journal-title":"Thromb. Res."},{"issue":"14","key":"75895_CR2","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1182\/blood.2020007338","volume":"137","author":"FI Mulder","year":"2021","unstructured":"Mulder, F. I. et al. Venous thromboembolism in cancer patients: a population-based cohort study. Blood. 137(14), 1959\u20131969 (2021).","journal-title":"Blood"},{"issue":"2","key":"75895_CR3","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1080\/10428194.2019.1666380","volume":"61","author":"V Bakalov","year":"2020","unstructured":"Bakalov, V. et al. Risk factors for venous thromboembolism in hospitalized patients with hematological malignancy: an analysis of the National Inpatient Sample, 2011\u20132015. Leuk. Lymphoma. 61(2), 370\u2013376 (2020).","journal-title":"Leuk. Lymphoma"},{"issue":"1","key":"75895_CR4","doi-asserted-by":"publisher","first-page":"101353","DOI":"10.1016\/j.beha.2022.101353","volume":"35","author":"TF Wang","year":"2022","unstructured":"Wang, T. F., Leader, A. & Sanfilippo, K. M. Thrombosis and bleeding in hematological malignancy. Best Pract. Res. Clin. Haematol.35(1), 101353 (2022).","journal-title":"Best Pract. Res. Clin. Haematol."},{"issue":"5","key":"75895_CR5","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1055\/s-0041-1725099","volume":"47","author":"ST Bonlokke","year":"2021","unstructured":"Bonlokke, S. T., Ommen, H. B. & Hvas, A. M. Altered fibrinolysis in Hematological Malignances. Semin Thromb. Hemost.47(5), 569\u2013580 (2021).","journal-title":"Semin Thromb. Hemost."},{"issue":"22","key":"75895_CR6","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1182\/bloodadvances.2019000369","volume":"3","author":"H Al-Samkari","year":"2019","unstructured":"Al-Samkari, H. & Connors, J. M. Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy. Blood Adv.3(22), 3770\u20133779 (2019).","journal-title":"Blood Adv."},{"issue":"1","key":"75895_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-022-00336-y","volume":"8","author":"AA Khorana","year":"2022","unstructured":"Khorana, A. A. et al. Cancer-associated venous thromboembolism. Nat. Rev. Dis. Primers. 8(1), 11 (2022).","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"4","key":"75895_CR8","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","volume":"5","author":"GH Lyman","year":"2021","unstructured":"Lyman, G. H. et al. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv.5(4), 927\u2013974 (2021).","journal-title":"Blood Adv."},{"issue":"6","key":"75895_CR9","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1111\/jth.14015","volume":"16","author":"BB Samuelson","year":"2018","unstructured":"Samuelson, B. B. et al. Management of cancer-associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH. J. Thromb. Haemost. 16(6), 1246\u20131249 (2018).","journal-title":"J. Thromb. Haemost"},{"issue":"2","key":"75895_CR10","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1007\/s11239-021-02393-8","volume":"52","author":"N Livneh","year":"2021","unstructured":"Livneh, N. et al. Anticoagulation in patients with atrial fibrillation, thrombocytopenia and hematological malignancy. J. Thromb. Thrombolysis. 52(2), 590\u2013596 (2021).","journal-title":"J. Thromb. Thrombolysis"},{"issue":"1","key":"75895_CR11","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1186\/s12877-022-03599-y","volume":"22","author":"L Li","year":"2022","unstructured":"Li, L. et al. The risk factors for deep venous thrombosis in critically ill older adult patients: a subgroup analysis of a prospective, multicenter, observational study. BMC Geriatr.22(1), 977 (2022).","journal-title":"BMC Geriatr."},{"issue":"4","key":"75895_CR12","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00277-022-04770-6","volume":"101","author":"F Martella","year":"2022","unstructured":"Martella, F. et al. Frequency and risk factors for thrombosis in acute myeloid leukemia and high-risk myelodysplastic syndromes treated with intensive chemotherapy: a two centers observational study. Ann. Hematol.101(4), 855\u2013867 (2022).","journal-title":"Ann. Hematol."},{"issue":"6","key":"75895_CR13","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s11864-023-01089-w","volume":"24","author":"M Olivi","year":"2023","unstructured":"Olivi, M. et al. Thrombosis in acute myeloid leukemia: pathogenesis, risk factors and therapeutic challenges. Curr. Treat. Options Oncol.24(6), 693\u2013710 (2023).","journal-title":"Curr. Treat. Options Oncol."},{"issue":"4","key":"75895_CR14","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3760\/cma.i.cn511693-20220509-00068","volume":"45","author":"L Chen","year":"2022","unstructured":"Chen, L., Zen, K. Y., Yao, H. & Chen, D. Research progress of characteristics, prevention and treatment of venous thrombosis in hematological malignancies patients. Int. J. Blood Transfus. Hematol.45(4), 346\u2013352. https:\/\/doi.org\/10.3760\/cma.i.cn511693-20220509-00068 (2022). (in Chese).","journal-title":"Int. J. Blood Transfus. Hematol."},{"issue":"4","key":"75895_CR15","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.21037\/apm-21-464","volume":"10","author":"X Chen","year":"2021","unstructured":"Chen, X., Huang, J., Liu, J., Deng, H. & Pan, L. Venous thromboembolism risk factors and prophylaxis of elderly intensive care unit patients in a Chinese general hospital. Ann. Palliat. Med.10(4), 4453\u20134462 (2021).","journal-title":"Ann. Palliat. Med."},{"issue":"Suppl 2","key":"75895_CR16","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1016\/S0049-3848(14)50019-9","volume":"133","author":"M Breccia","year":"2014","unstructured":"Breccia, M. & Lo, C. F. Thrombo-hemorrhagic deaths in acute promyelocytic leukemia. Thromb. Res.133(Suppl 2), S112\u2013S116 (2014).","journal-title":"Thromb. Res."},{"issue":"4","key":"75895_CR17","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s11239-020-02274-6","volume":"51","author":"C G\u00f3mez-Cuervo","year":"2021","unstructured":"G\u00f3mez-Cuervo, C. et al. Predicting the risk for major bleeding in elderly patients with venous thromboembolism using the Charlson index. Findings from the RIETE. J. Thromb. Thrombolysis. 51(4), 1017\u20131025 (2021).","journal-title":"J. Thromb. Thrombolysis"},{"issue":"Suppl 1","key":"75895_CR18","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/j.thromres.2022.01.008","volume":"213","author":"KM Sanfilippo","year":"2022","unstructured":"Sanfilippo, K. M. Venous thromboembolism and risk stratification in hematological malignancies. Thromb. Res.213(Suppl 1), S16\u201321 (2022).","journal-title":"Thromb. Res."},{"issue":"11","key":"75895_CR19","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1080\/10428194.2017.1306644","volume":"58","author":"DE Houghton","year":"2017","unstructured":"Houghton, D. E. et al. Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohort. Leuk. Lymphoma. 58(11), 2573\u20132581 (2017).","journal-title":"Leuk. Lymphoma"},{"issue":"5","key":"75895_CR20","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1200\/JCO.19.01461","volume":"38","author":"NS Key","year":"2020","unstructured":"Key, N. S. et al. Venous thromboembolism prophylaxis and treatment in patients with Cancer: ASCO Clinical Practice Guideline Update. J. Clin. Oncol.38(5), 496\u2013520 (2020).","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"75895_CR21","doi-asserted-by":"publisher","first-page":"e566","DOI":"10.1016\/S1470-2045(19)30336-5","volume":"20","author":"D Farge","year":"2019","unstructured":"Farge, D. et al. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. Lancet Oncol.20(10), e566\u2013e581 (2019).","journal-title":"Lancet Oncol."},{"key":"75895_CR22","doi-asserted-by":"publisher","DOI":"10.13286\/j.1001-5213.2021.03.09","author":"T Liang","year":"2021","unstructured":"Liang, T. et al. Analyzing and predicting the risk of hemorrhage induced by rivaroxaban. Chin. J. Hosp. Pharm.https:\/\/doi.org\/10.13286\/j.1001-5213.2021.03.09 (2021). (in Chese).","journal-title":"Chin. J. Hosp. Pharm."},{"issue":"22","key":"75895_CR23","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.2146\/ajhp180031","volume":"75","author":"AE Woodruff","year":"2018","unstructured":"Woodruff, A. E., Wovkulich, M. M., Mogle, B. T. & Hassan, A. K. Association between prothrombin time and bleeding in hospitalized patients receiving rivaroxaban. Am. J. Health Syst. Pharm.75(22), 1783\u20131789 (2018).","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"13","key":"75895_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.6004\/jnccn.2021.7108","volume":"20","author":"A Elshoury","year":"2022","unstructured":"Elshoury, A., Schaefer, J. K., Lim, M. Y., Skalla, D. P. & Streiff, M. B. Update on guidelines for the prevention of cancer-associated thrombosis. J. Natl. Compr. Canc Netw.20(13), 1\u20138 (2022).","journal-title":"J. Natl. Compr. Canc Netw."},{"issue":"12","key":"75895_CR25","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1080\/10428194.2023.2247513","volume":"64","author":"O Jarchowsky","year":"2023","unstructured":"Jarchowsky, O., Avnery, O. & Ellis, M. H. Thrombosis in multiple myeloma: mechanisms, risk assessment and management. Leuk. Lymphoma. 64(12), 1905\u20131913 (2023).","journal-title":"Leuk. Lymphoma"},{"issue":"5","key":"75895_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.revmed.2019.12.013","volume":"41","author":"C Mornet","year":"2020","unstructured":"Mornet, C., Galinat, H., Mingant, F., Ianotto, J. C. & Lippert, E. Thromboses et thrombopathies dans les syndromes my\u00e9loprolif\u00e9ratifs [Thrombosis and platelet dysfunction in myeloproliferative neoplasms]. Rev. Med. Interne. 41(5), 319\u2013324 (2020).","journal-title":"Rev. Med. Interne"},{"key":"75895_CR27","doi-asserted-by":"crossref","unstructured":"Paterno, G. et al. Predictors of early thrombotic events in adult patients with Acute myeloid leukemia: a real-world experience. Cancers. 14(22), 5640 (2022).","DOI":"10.3390\/cancers14225640"},{"issue":"40","key":"75895_CR28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.19538\/j.cips.issn1005-2208.2020.04.03","volume":"04","author":"Chinese Chapter of the International of Angiology; Peripheral Vascular Disease Chapter, Chinese Geriatrics Society","year":"2020","unstructured":"Chinese Chapter of the International of Angiology; Peripheral Vascular Disease Chapter, Chinese Geriatrics Society. Chinese expert consensus on prevention and treatment catheter related venous thrombosis (2020 edition). Chin. J. Practical Surg.04(40), 377\u2013383. https:\/\/doi.org\/10.19538\/j.cips.issn1005-2208.2020.04.03 (2020). (in Chese).","journal-title":"Chin. J. Practical Surg."},{"issue":"2","key":"75895_CR29","doi-asserted-by":"publisher","first-page":"2253822","DOI":"10.1080\/07853890.2023.2253822","volume":"55","author":"WS Kim","year":"2023","unstructured":"Kim, W. S. et al. Re-bleeding and all-cause mortality risk in non-variceal upper gastrointestinal bleeding: focusing on patients receiving oral anticoagulant therapy. Ann. Med.55(2), 2253822 (2023).","journal-title":"Ann. Med."},{"key":"75895_CR30","doi-asserted-by":"publisher","unstructured":"Falanga A, Rickles FR. Management of Thrombohemorrhagic Syndromes (THS) in hematologic malignancies. Hematol. Am. Soc. Hematol. Educ. Program. 165\u2013171. https:\/\/doi.org\/10.1182\/asheducation-2007.1.165 (2007).","DOI":"10.1182\/asheducation-2007.1.165"},{"issue":"4","key":"75895_CR31","doi-asserted-by":"publisher","first-page":"482","DOI":"10.2174\/157016110791330799","volume":"8","author":"R Castelli","year":"2010","unstructured":"Castelli, R., Ferrari, B., Cortelezzi, A. & Guariglia, A. Thromboembolic complications in malignant haematological disorders. Curr. Vasc Pharmacol.8(4), 482\u2013494 (2010).","journal-title":"Curr. Vasc Pharmacol."},{"issue":"4","key":"75895_CR32","first-page":"237","volume":"05","author":"\u0414\u041f \u041f\u0430\u0432\u043b\u043e\u0432\u0441\u043a\u0438\u0439","year":"1982","unstructured":"\u041f\u0430\u0432\u043b\u043e\u0432\u0441\u043a\u0438\u0439, \u0414. \u041f. & Han, Z. W. Thrombotic haemorrhagic syndrome in tumour patients. Int. J. Blood Transfus. Hematol.05(4), 237\u2013239 (1982). (in Chese).","journal-title":"Int. J. Blood Transfus. Hematol."},{"issue":"3","key":"75895_CR33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1600-0609.2006.00803.x","volume":"78","author":"M Yanada","year":"2007","unstructured":"Yanada, M. et al. Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome. Eur. J. Haematol.78(3), 213\u2013219 (2007).","journal-title":"Eur. J. Haematol."},{"issue":"4","key":"75895_CR34","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s11239-017-1539-4","volume":"44","author":"BB Samuelson","year":"2017","unstructured":"Samuelson, B. B., Walter, R. B., Gernsheimer, T. B. & Garcia, D. A. Patients treated for acute VTE during periods of treatment-related thrombocytopenia have high rates of recurrent thrombosis and transfusion-related adverse outcomes. J. Thromb. Thrombolysis. 44(4), 442\u2013447 (2017).","journal-title":"J. Thromb. Thrombolysis"},{"issue":"6","key":"75895_CR35","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/j.1365-2141.2005.05529.x","volume":"129","author":"A Cortelezzi","year":"2005","unstructured":"Cortelezzi, A. et al. Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study. Br. J. Haematol.129(6), 811\u2013817 (2005).","journal-title":"Br. J. Haematol."},{"issue":"12","key":"75895_CR36","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s00277-016-2798-4","volume":"95","author":"M Refaei","year":"2016","unstructured":"Refaei, M. et al. Incidence of catheter-related thrombosis in acute leukemia patients: a comparative, retrospective study of the safety of peripherally inserted vs. centrally inserted central venous catheters. Ann. Hematol.95(12), 2057\u20132064 (2016).","journal-title":"Ann. Hematol."},{"issue":"5","key":"75895_CR37","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.annonc.2022.12.014","volume":"34","author":"A Falanga","year":"2023","unstructured":"Falanga, A. et al. Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline. Ann. Oncol.34(5), 452\u2013467 (2023).","journal-title":"Ann. Oncol."},{"issue":"1","key":"75895_CR38","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1002\/onco.13596","volume":"26","author":"MB Streiff","year":"2021","unstructured":"Streiff, M. B. et al. Update on guidelines for the management of Cancer-Associated thrombosis. Oncologist. 26(1), e24\u201340 (2021).","journal-title":"Oncologist"},{"issue":"7","key":"75895_CR39","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1016\/S1470-2045(22)00160-7","volume":"23","author":"D Farge","year":"2022","unstructured":"Farge, D. et al. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19. Lancet Oncol.23(7), e334\u2013e347 (2022).","journal-title":"Lancet Oncol."},{"issue":"8","key":"75895_CR40","doi-asserted-by":"publisher","first-page":"e750","DOI":"10.1097\/HS9.0000000000000750","volume":"6","author":"A Falanga","year":"2022","unstructured":"Falanga, A. et al. EHA guidelines on management of antithrombotic treatments in thrombocytopenic patients with Cancer. Hemasphere. 6(8), e750 (2022).","journal-title":"Hemasphere"},{"issue":"10","key":"75895_CR41","first-page":"1181","volume":"19","author":"MB Streiff","year":"2021","unstructured":"Streiff, M. B. et al. Cancer-Associated venous thromboembolic Disease, Version 2.2021, NCCN Clinical Practice guidelines in Oncology. J. Natl. Compr. Canc Netw.19(10), 1181\u20131201 (2021).","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"75895_CR42","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.thromres.2020.12.016","volume":"199","author":"F Moik","year":"2021","unstructured":"Moik, F., Makatsariya, A. & Ay, C. Challenging anticoagulation cases: cancer-associated venous thromboembolism and chemotherapy-induced thrombocytopenia - a case-based review of clinical management. Thromb. Res.199, 38\u201342 (2021).","journal-title":"Thromb. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75895-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75895-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75895-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T01:16:37Z","timestamp":1729386997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75895-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,16]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["75895"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-75895-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,16]]},"assertion":[{"value":"11 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by Mianyang Central Hospital (Mianyang, China; approval no. S-2024-0208-01). The patients\/participants provided written informed consent to participate in this study. All methods were performed in accordance with the relevant guidelines and regulations, including the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24272"}}